Stockreport

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study [Yahoo! Finance]

Talphera, Inc.  (TLPH) 
PDF The FDA agreed to two additional protocol changes expected to accelerate enrollment in the NEPHRO CRRT study SAN MATEO, Calif. Jan. 14, 2025 /PRNewswire/ -- Talphera, [Read more]